Moderna has received the necessary approval for a new vaccine

Biotech company Moderna Inc. (MRNA) has received permission from the UK regulator to sell a vaccine against new varieties of COVID-19. Moderna has received permission to use the “new generation vaccine from COVID-19” in the UK. In the company, a bivalent booster vaccine against COVID-19 containing mRNA-1273.214 is the first time regulators have approved a bivalent vaccine designed to combat the omicron variant. 

So far, the vaccine has been approved for 18 years and older, but as new safety data become available, it may expand the age range. The mRNA-1273.214 vaccine combines Spikevax from the original COVID-19 strain and a new compound targeting the omicron BA variant.1. According to Moderna’s management, a bivalent vaccine will better cope with the latest variant of the virus. Positive clinical data from Phase II/III trials confirm the words of Moderna. The tests showed that the booster dose of the bivalent vaccine increased the neutralizing titers against omicron by about eight times compared to the baseline level. 

In addition, the vaccine has also shown strong results in the fight against new omicron variants, including BA.4 and BA.5. Thus, Moderna does not stop making money on COVID-19 vaccines. The epidemiological situation shows that the demand for coronavirus prevention will continue for some time, although the omicron strain seems less dangerous than its predecessors. At the same time, it is difficult to predict how many vaccines Moderna will be able to sell in reality. 

The company receives orders from governments of different countries, but often the demand for vaccinations is less than predicted, which forces Moderna to destroy huge batches. Second-quarter financial report, management announced the write-off of vaccines worth almost half a billion dollars, the expiration date of which has expired. The advantage of Moderna is that it now conducts many mRNA-based programs that are not related to COVID-19 means that in the long run, she will be able to benefit from other projects.